Blood-based extracellular matrix biomarkers are correlated with clinical outcome after PD-1 inhibition in patients with metastatic melanoma

Daan Hurkmans; C Jensen; Stijn Koolen; Joachim Aerts; MA Karsdal; Ron Mathijssen; N Willumsen

doi:10.1136/jitc-2020-001193

Blood-based extracellular matrix biomarkers are correlated with clinical outcome after PD-1 inhibition in patients with metastatic melanoma

Daan Hurkmans, C Jensen, Stijn Koolen, Joachim Aerts, MA Karsdal, Ron Mathijssen, N Willumsen

Research output: Contribution to journal › Article › Academic › peer-review

19 Citations (Scopus)

4 Downloads (Pure)

Original language	English
Article number	e001193
Journal	Journal for ImmunoTherapy of Cancer
Volume	8
Issue number	2
DOIs	https://doi.org/10.1136/jitc-2020-001193
Publication status	Published - 2020

Access to Document

10.1136/jitc-2020-001193

Repub_132073_O-A.pdfFinal published version, 1.67 MB

http://hdl.handle.net/1765/132073

Cite this

@article{943edcc84a5d4447b2fd788d1a651ae7,

title = "Blood-based extracellular matrix biomarkers are correlated with clinical outcome after PD-1 inhibition in patients with metastatic melanoma",

author = "Daan Hurkmans and C Jensen and Stijn Koolen and Joachim Aerts and MA Karsdal and Ron Mathijssen and N Willumsen",

year = "2020",

doi = "10.1136/jitc-2020-001193",

language = "English",

volume = "8",

journal = "Journal for ImmunoTherapy of Cancer",

issn = "2051-1426",

publisher = "BioMed Central Ltd.",

number = "2",

}

TY - JOUR

T1 - Blood-based extracellular matrix biomarkers are correlated with clinical outcome after PD-1 inhibition in patients with metastatic melanoma

AU - Hurkmans, Daan

AU - Jensen, C

AU - Koolen, Stijn

AU - Aerts, Joachim

AU - Karsdal, MA

AU - Mathijssen, Ron

AU - Willumsen, N

PY - 2020

Y1 - 2020

U2 - 10.1136/jitc-2020-001193

DO - 10.1136/jitc-2020-001193

M3 - Article

VL - 8

JO - Journal for ImmunoTherapy of Cancer

JF - Journal for ImmunoTherapy of Cancer

SN - 2051-1426

IS - 2

M1 - e001193

ER -